Polyethylene Glycol (PEGs & PEOs)

m-PEG-CH2CO2H, MW2K is a PEG derivative with a terminal carboxylic acid group. The terminal carboxylic acid can react with primary amines in the presence of activators such as EDC and DCC to form stable amide bonds. The hydrophilic PEG linker

m-PEG-CH2CO2H, MW5K contains a hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond.

m-PEG-CH2CO2H, MW5K contains a hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond.

m-PEG-CH2CO2H, MW20K is a PEG derivative with a terminal carboxylic acid group. The terminal carboxylic acid can react with primary amines in the presence of activators such as EDC and DCC to form stable amide bonds. The hydrophilic PEG linker

m-PEG-CH2CO2H, MW20K is a PEG derivative with a terminal carboxylic acid group. The terminal carboxylic acid can react with primary amines in the presence of activators such as EDC and DCC to form stable amide bonds. The hydrophilic PEG linker

m-PEG-DSPE, MW 30K is a PEG derivative containing a DSPE group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

m-PEG-DSPE, MW 30K is a PEG derivative containing a DSPE group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

m-PEG-DSPE, MW 1K is a PEG derivative containing a DSPE group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

m-PEG-DSPE, MW 1K is a PEG derivative containing a DSPE group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

m-PEG-DSPE, MW 5K is a PEG derivative containing a DSPE group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

m-PEG-DSPE, MW 5K is a PEG derivative containing a DSPE group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

m-PEG-DSPE, MW 2K is a PEG derivative containing a DSPE group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The